Fundz

Enveric Biosciences, Inc. reported raising $12.8 Million in an initial SEC Form D filing, from an offering of $8.25 Million

PUBLIC · ENVBJan 20, 2021

Amount Raised

$12.8 Million

$12.8 Million sold, per SEC Form D (first sale Jan 20, 2021)

Round Type

Venture

CambridgeBiotechnologyHealthcareHealth CareScience And Engineering

Quick answer

Enveric Biosciences raised $12.8 Million in a funding round, dated January 20, 2021. Enveric Biosciences is based in Cambridge, Massachusetts, United States.

How much did Enveric Biosciences raise?
Enveric Biosciences raised $12.8 Million in a funding round on January 20, 2021.
What does Enveric Biosciences do?
Enveric Biosciences (NASDAQ: ENVB) is an innovative biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform, leveraging psychedelic-derived molecules for the..
Where is Enveric Biosciences based and how big is it?
Enveric Biosciences is based in Cambridge, Massachusetts, United States. Fundz records about 12 employees.
Who are the decision-makers at Enveric Biosciences?
Fundz holds 2 contacts at Enveric Biosciences, including the Director of Preclinical Development. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Science And Engineering around the same time

Companies in the same sectors as Enveric Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Variantyx raised $16M on March 5, 2021.
  • Exscientia raised $100M (Series C) on March 4, 2021.
  • Geneos Therapeutics raised $12M (Series A) on March 3, 2021.
  • BlossomHill Therapeutics raised $71M on March 1, 2021.
  • Alumis raised $11M on February 25, 2021.
  • Pneuma Respiratory raised $430K on February 18, 2021.

Who to call at Enveric Biosciences, and when

A new round usually means Enveric Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Enveric Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Enveric Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Enveric Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Enveric Biosciences

Location

Cambridge, Massachusetts, United States

About

Enveric Biosciences (NASDAQ: ENVB) is an innovative biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform, leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body. Enveric's robust pipeline supports drug development from the clinic to commercialization for millions of patients in need around the world suffering from conditions that include cancer-related distress, PTSD and more.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Enveric Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsSheetal R., Director of Preclinical DevelopmentSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Enveric Biosciences's next move

See what Strategic adds

Enveric Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.